Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases
Titel:
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases
Auteur:
Dohm, Ammoren E. Nakashima, Justyn Y. Kalagotla, Hruday Jiang, Shirley X. Tang, Joseph D. Bhandari, Menal Kim, Youngchul Graham, Jasmine A. Khushalani, Nikhil I. Forsyth, Peter A. Etame, Arnold B. Liu, James K. Tran, Nam D. Vogelbaum, Michael A. Wuthrick, Evan J. Yu, Hsiang-Hsuan Michael Oliver, Daniel E. Ahmed, Kamran A.